Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult men who meet any one of the following criteria: (1) Patient who is diagnosed as prostate cancer, and undergo CT and/or bone scintigraphy or will undergo. (2) Patient who represent PSA elevation after local treatment (surgery or radiotherapy) for prostate cancer, and undergo CT and/or bone scintigraphy or will undergo (so-called PSA failure) (3) Patient with castration-resistant prostate cancer without metastasis on CT or bone scintigraphy who will undergo treatment using oral androgen receptor signaling inhibitors (4) Patient with castration-resistant prostate cancer who is confirmed metastasis by CT and/or bone scintigraphy
Exclusion criteria
Exclusion criteria: (1) Patient who cannot keep the body position for 30 minutes. (2) Others who are regarded as unsuitable for enrollment in the opinion of research staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) PSMA-PET findings compared with conventional imaging findings of CT / bone scintigraphy etc. before treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 2) Comparison of pathological findings after surgery or biopsy and PSMA-PET-positive lesions 3) Follow-up of PSMA-PET compared to conventional imaging findings of CT / bone scintigraphy etc. after treatment | — |
Countries
Japan
Contacts
Osaka University Graduate School of Medicine Nuclear Medicine and Tracer Kinetics